fda removes semaglutide from drug shortage list february 2025 Hims & Hers stock falls 25% as curtails compounded GLP-1s The FDA Wins. The OFA

If you or someone you know has been searching for solutions to control high blood sugar or to jump-start their weight loss treatment journey, then understanding what this medication does might be incredibly valuable

But so far, the safety profile looks manageable

By acting as a potent Nrf2 agonist, sulforaphane chemically modifies the Keap1 repressor protein, allowing Nrf2 to flood into the cell nucleus

The original version of SB 282 would have regulated all medications produced by compound pharmacies, but senators approved amendments to narrow the bills focus to just GLP-1 drugs

Gastric slowing: GLP-1 slows how quickly food leaves your stomach, reducing post-meal glucose spikes and prolonging satiety